Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study.
Ogata A, Amano K, Dobashi H, Inoo M, Ishii T, Kasama T, Kawai S, Kawakami A, Koike T, Miyahara H, Miyamoto T, Munakata Y, Murasawa A, Nishimoto N, Ogawa N, Ojima T, Sano H, Shi K, Shono E, Suematsu E, Takahashi H, Tanaka Y, Tsukamoto H, Nomura A; MUSASHI Study Investigators. Ogata A, et al. Among authors: takahashi h. J Rheumatol. 2015 May;42(5):799-809. doi: 10.3899/jrheum.140665. Epub 2015 Apr 1. J Rheumatol. 2015. PMID: 25834203 Clinical Trial.
Long-term efficacy and safety results from an open-label phase III study (UNCOVER-J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab.
Umezawa Y, Torisu-Itakura H, Morisaki Y, ElMaraghy H, Nakajo K, Akashi N, Saeki H; Japanese Ixekizumab Study Group. Umezawa Y, et al. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):568-576. doi: 10.1111/jdv.15292. Epub 2018 Nov 13. J Eur Acad Dermatol Venereol. 2019. PMID: 30325534 Free PMC article. Clinical Trial.
Dichotomous dynamics of magnetic monopole fluids.
Hsu CC, Takahashi H, Jerzembeck F, Dasini J, Carroll C, Dusad R, Ward J, Dawson C, Sharma S, Luke GM, Blundell SJ, Castelnovo C, Hallén JN, Moessner R, Davis JCS. Hsu CC, et al. Among authors: takahashi h. Proc Natl Acad Sci U S A. 2024 May 21;121(21):e2320384121. doi: 10.1073/pnas.2320384121. Epub 2024 May 14. Proc Natl Acad Sci U S A. 2024. PMID: 38743620
High-mobility group box 1 fragment ameliorates chronic pancreatitis induced by caerulein in mice.
Hokkoku D, Sasaki K, Kobayashi S, Shimbo T, Kitayama T, Yamazaki S, Yamamoto Y, Ouchi Y, Imamura H, Kado T, Toya K, Fujii W, Iwagami Y, Yamada D, Tomimaru Y, Noda T, Takahashi H, Tamai K, Doki Y, Eguchi H. Hokkoku D, et al. Among authors: takahashi h. J Gastroenterol. 2024 May 10. doi: 10.1007/s00535-024-02112-z. Online ahead of print. J Gastroenterol. 2024. PMID: 38727823
ASO Author Reflections: Which was the Better Regimen (Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1) as Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma (R/BR-PDAC)?
Yamada D, Kobayashi S, Takahashi H, Iwagami Y, Akita H, Asukai K, Shimizu J, Yamada T, Tanemura M, Yokoyama S, Tsujie M, Asaoka T, Takeda Y, Morimoto O, Tomokuni A, Doki Y, Eguchi H. Yamada D, et al. Among authors: takahashi h. Ann Surg Oncol. 2024 May 9. doi: 10.1245/s10434-024-15244-6. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38722422 No abstract available.
14,169 results
You have reached the last available page of results. Please see the User Guide for more information.